2017年7月1日星期六

Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trial

Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trial

M Boffito, J Fox, C Bowman, M Fisher, C Orkin… - Vaccine, 2013 - Elsevier
... of the following four multi-epitope polypeptides manufactured by Fmoc chemistry (Bachem AG,
Switzerland ... Several peptide based HIV vaccines have been clinically tested previously. Most
contained combinations of ENV, GAG, TAT, NEF and POL derived peptides [18], [19], [20 ...



Peptide synthesis, peptide modification and peptide library synthesis, please contact:
Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com

没有评论:

发表评论